EU regulator to probe ethical standards of Sputnik vaccine trials - FT


A dose of Russia's Sputnik V coronavirus disease (COVID-19) vaccine is prepared at a sport centre, as the country starts mass inoculation campaign with the Russian vaccine donated by Serbia, in Skopje, North Macedonia April 5, 2021. REUTERS/Ognen Teofilovski

(Reuters) - The EU drug regulator will begin investigations next week on whether clinical trials of Russia's Sputnik V COVID-19 vaccine followed global clinical and scientific guidelines, the Financial Times reported on Wednesday.

The European Medicines Agency's probe comes as people familiar with the regulator's approval process told the FT that Sputnik V trials had not been ethically run.

Kirill Dmitriev, head of Russia's Direct Investment Fund, told the newspaper, "There was no pressure (on participants) and Sputnik V complied with all clinical practices".

(Reporting by Aakriti Bhalla in Bengaluru; Editing by Jacqueline Wong)

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 46
Cxense type: free
User access status: 3
   

Next In World

Brazil sees 1,803 COVID-19 deaths; Chinese vaccine found 50.7% effective against variant
'The right path' - Chile defends Sinovac use amid fresh efficacy questions
English shops and pub gardens reopen in 'major step' to freedom
Saudi-led coalition intercepts explosive-laden drones launched by Yemen's Houthis - state TV
French government disgusted by attack on Muslim centre
Tanzania opposition calls for new constitution, faster COVID-19 research
At least four migrants found dead on boat off Canary Islands
Power outages hit Saint Vincent island amid volcano tremors
Blinken to return to Brussels for talks on Ukraine, Afghanistan
British royals react to Prince Philip's death

Stories You'll Enjoy


Vouchers